Crossmark

Evaluation of the effectiveness and costs of inhaled methoxyflurane versus usual analgesia for prehospital injury and trauma: non-randomised clinical study

Crossref DOI link: https://doi.org/10.1186/s12873-022-00664-y

Published Online: 2022-07-07

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Smith, Murray D. https://orcid.org/0000-0002-5363-4184
Rowan, Elise

Spaight, Robert

Siriwardena, Aloysius N.
Funding

Funding for this research was provided by:

Galen Ltd
License Information

Text and Data Mining valid from 2022-07-07

Version of Record valid from 2022-07-07
More Information

Article History

Received: 16 February 2022

Accepted: 1 June 2022

First Online: 7 July 2022

Declarations

:

: The study received ethical approval on 9 December 2019 from the University of Lincoln Human Ethics Committee. Informed consent was obtained from all subjects and/or their legal guardian(s)<b>.</b>

: Not applicable.

: The authors declare that they have no competing interests. ANS is on the editorial board for BMC Emergency Medicine.

Document is current

Any future updates will be listed below